BioLineRx Ltd. (BLRX) News
Follow BioLineRx Ltd. (BLRX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BLRX - BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meet
BLRX - BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)
EQUITY | Sep 10, 2026, 11:01 AM UTC
L
BioLine RX Ltd expected to post breakeven results a share - Earnings Preview
BioLine RX Ltd expected to post breakeven results a share - Earnings Preview
EARNINGS | Aug 28, 2026, 12:32 PM UTC
M
BioLineRx announces $3.75 million registered direct offering
BioLineRx announced a $3.75 million registered direct offering and a concurrent private placement.
EQUITY | Aug 28, 2026, 12:00 PM UTC
L
BioLineRx schedules Q2 2026 results for Aug. 31, 2026
BioLineRx (BLRX) will report its second-quarter 2026 results on August 31, 2026, according to TradeXchange Newsdesk.
EARNINGS | Aug 25, 2026, 11:00 AM UTC